Abbott Laboratories is set for growth in 2025 with strong drivers like Libre, TriClip, and Aveir. Expectations include high single-digit organic sales growth and double-digit EPS growth driven by top-line performance and product expansion, aiming to maintain a competitive edge in various healthcare segments.